PDS Biotechnology reports Arnold Banaag as director

PDS Biotechnology Corp (PDSB) reported that Arnold James Banaag is a director of the company in an initial statement of beneficial ownership on Form 3.

Available on EDGAR 09/21/2026 - 08:39 PM EDT Accepted by SEC EDGAR 09/21/2026 - 08:38 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

PDS Biotechnology Corp (PDSB) reported that Arnold James Banaag is a director of the company in an initial statement of beneficial ownership on Form 3. The filing lists no equity holdings or transactions for him at this time, so it functions primarily as a role-identification disclosure.

Key Terms

Form 3, beneficial ownership, director

3 terms

Form 3 regulatory

"an initial statement of beneficial ownership on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"an initial statement of beneficial ownership on Form 3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

director financial

"reported that Arnold James Banaag is a director of the company"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing for PDSB disclose about Arnold James Banaag?

It discloses that Arnold James Banaag is a director of PDS Biotechnology Corp. The Form 3 is an initial statement of beneficial ownership and currently shows no reported holdings or transactions for him.

Are any share purchases or sales reported for Arnold James Banaag in this PDSB Form 3?

No. The Form 3 for PDSB shows no reported transactions, with buy, sell, acquire, and dispose counts all at zero for Arnold James Banaag.

Does the PDSB Form 3 indicate that Arnold James Banaag owns any PDS Biotechnology shares?

The Form 3 lists no holdings entries for Arnold James Banaag. It does not report any specific number of shares or derivative securities owned as of the filing.

Is Arnold James Banaag reported as a 10% owner or officer of PDS Biotechnology Corp (PDSB)?

No. The filing identifies Arnold James Banaag only as a director. He is not marked as an officer or a ten percent owner in this Form 3.

Does the PDSB Form 3 mention a Rule 10b5-1 trading plan for Arnold James Banaag?

No. The Rule 10b5-1 checkbox field is null, indicating no plan status is stated. Combined with the absence of transactions, the Form 3 provides no information about any trading plans.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Banaag Arnold James

(Last) (First) (Middle)

C/O PDS BIOTECHNOLOGY CORPORATION

303A COLLEGE ROAD EAST

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/14/2026

3. Issuer Name and Ticker or Trading Symbol
PDS Biotechnology Corp [ PDSB ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Arnold James Banaag	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)